검색어: osteoclastic (영어 - 몰타어)

it is an inhibitor of osteoclastic bone resorption.
hu impeditur tal-assorbiment mill-ġdid tal-għadam osteoklastiku.

inhibition of osteoclastic bone resorption, which alters the bone marrow
impediment tar- risorbiment ta ’ l- għadam minn osteoklasts, biex b’ hekk ibiddlu l- mikro -

animal models confirm that ibandronic acid is a highly potent inhibitor of osteoclastic activity.
mudelli ta’ l-annimali jikkonfermaw li ibandronic acid huwa inibitur qawwi ħafna ta’ l-attività osteoklastika.

alendronate sodium is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation.
alendronate sodium huwa bisphosphonate li jimpedixxi l-assorbiment osteoklastiku mill-ġdid tal- għadam mingħajr effett dirett fuq il-formazzjoni tal-għadam.

alendronate alendronate sodium is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation.
alendronate alendronate sodium huwa bisphosphonate li jimpedixxi l- assorbiment osteoklastiku mill- ġdid ta ’ l - għadam mingħajr effett dirett fuq il- formazzjoni ta ’ l- għadam.

once-daily administration of forsteo increases apposition of new bone on trabecular and cortical bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.
l-għotja ta’ forsteo darba kuljum iżżid il-formazzjoni ta’ għadam ġdid fis-superfiċje ta’ l-għadam trabekulari u kortikali, permezz ta’ stimolu preferenzjali ta’ attivita’ osteoblastika fuq attivita’ osteoklastika.

the selective action of bisphosphonates on bone is based on their high affinity for mineralised bone, but the precise molecular mechanism leading to the inhibition of osteoclastic activity is still unclear.
il-mod selettiv ta’ kif jaħdmu l-bisfosfonati fuq l-għadam ġej mill-affinità qawwija li għandhom għall- għadam mineralizzat, iżda l-mekkaniżmu preċiż fuq livell molekulari li jwassal għall- impediment tal- attività tal-osteoklasts għadu mħux magħruf għal kollox.

in vivo: inhibition of osteoclastic bone resorption, which alters the bone marrow microenvironment, making it less conducive to tumour cell growth and anti-angiogenic activity.
in vivo: impediment tar-risorbiment tal-għadam minn osteoklasts, biex b’hekk ibiddlu l-mikro- ambjent tal-mudullun u allura titnaqqaslu l-ħila li jkattar iċ-ċelloli tat-tumur, għandu effett kontra t-tkattir mill-ġdid tal-provvista ta’ demm lit-tumur u effett kontra l-uġigħ.

transient elevations in parathyroid hormone levels after subcutaneous injection of preotact stimulates new bone formation on trabecular and cortical (periosteal and/or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.
iż- żidiet għaddiena fil-livelli ta’ l-ormon tal-paratirojde wara injezzjoni taħt il-ġilda ta’ preotact jistimulaw il-formazzjoni ġdida ta’ l-għadam fuq is-superfiċje ta’ l-għadam trabekulari u kortikali (perjosteali u/jew endosteali) bi stimulazzjoni preferenzjali ta’ l-attività osteoblastika fuq l-attività osteoklastika.